These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9161118)

  • 1. Quality of life claims in trials of anti-hypertensive therapy.
    Hunt SM
    Qual Life Res; 1997 Mar; 6(2):185-91. PubMed ID: 9161118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of quality of life in hypertensive patients: a practical approach.
    Bulpitt CJ; Fletcher AE
    Br J Clin Pharmacol; 1990 Sep; 30(3):353-64. PubMed ID: 2223414
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality-of-life measures in the evaluation of antihypertensive drug therapy: reliability, validity, and quality-of-life domains.
    Gandhi SK; Kong SX
    Clin Ther; 1996; 18(6):1276-95. PubMed ID: 9001843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients treated for hypertension: a review of the literature from 1990 to 2000.
    Coyne KS; Davis D; Frech F; Hill MN
    Clin Ther; 2002 Jan; 24(1):142-69. PubMed ID: 11833829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility and validity of quality of life measurements in hypertensive patients on stable medication.
    Krijnen P; van Jaarsveld BC; Man in 't Veld AJ; Habbema JD
    Neth J Med; 1997 Apr; 50(4):137-52. PubMed ID: 9130837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in hypertensive patients on different antihypertensive treatments: rationale for methods employed in a multicenter randomized controlled trial.
    Bulpitt CJ; Fletcher AE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S137-45. PubMed ID: 2580168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of determinants of health-related quality of life in hypertensive patients and normal population in south-west Nigeria.
    Adedapo AD; Akunne OO; Adedokun BO
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):265-71. PubMed ID: 25613540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive medication and quality of life--silent treatment of a silent killer?
    Bremner AD
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):353-64. PubMed ID: 12652105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and its impact on hypertensive patients.
    Williams GH
    Am J Med; 1987 Jan; 82(1):98-105. PubMed ID: 3799696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the effects of antihypertensive therapy upon the quality of life.
    Fletcher A
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):538-42. PubMed ID: 8591065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting quality-of-life clinical trial data for use in the clinical practice of antihypertensive therapy.
    Testa MA
    J Hypertens Suppl; 1987 Feb; 5(1):S9-13. PubMed ID: 3553497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice. The OCAPI Study Group. Optimiser le Choix d'un Anti-hypertenseur de Première Intention.
    Boissel JP; Collet JP; Lion L; Ducruet T; Moleur P; Luciani J; Milon H; Madonna O; Gillet J; Gerini P
    J Hypertens; 1995 Sep; 13(9):1059-67. PubMed ID: 8586825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-adjusted meta-analysis of the hypertension/coronary dilemma.
    Holme I; Ekelund LG; Hjermann I; Leren P
    Am J Hypertens; 1994 Aug; 7(8):703-12. PubMed ID: 7986460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life during antihypertensive treatment. Lessons from the Systolic Hypertension in the Elderly Program.
    Applegate WB
    Am J Hypertens; 1998 Mar; 11(3 Pt 2):57S-61S. PubMed ID: 9546039
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of antihypertensive agents on quality of life in the elderly.
    Fogari R; Zoppi A
    Drugs Aging; 2004; 21(6):377-93. PubMed ID: 15084140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life under antihypertensive treatment.
    Schoenberger JA
    Drugs; 1988; 35 Suppl 5():74-9. PubMed ID: 3063487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of antihypertensive drug therapy on quality of life.
    Scherger JE
    Postgrad Med; 2000 Oct; 108(5 Suppl):25-9. PubMed ID: 19667538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.